CRN Sees Voluntary Supplement Registry Bringing Regulatory Plus Retail Benefits
This article was originally published in The Tan Sheet
While an industry-run registry would not conduct pre-market evaluations nor state that a product’s health claims and ingredients are compliant, retailers and other businesses selling supplements could see it as a seal of approval.
You may also be interested in...
Oversight authorized by DSHEA “is not the regulatory system for dietary supplements sold to the American public,” says former FDA official Joshua Sharfstein.
Industry trade groups say FDA decision against starting rulemaking for lawful use of hemp ingredients is not only overdue but failed to clear the air for businesses making or using the ingredients.
It could take next farm bill, on lawmakers’ 2023 to-do list, to extinguish inferno of disagreement between FDA and regulated industries over lawful use of hemp-based ingredients in supplements as well as food and non-drug topicals. Before 2018 bill de-scheduled hemp, 2014 bill expanded access to hemp for research.